Elizabeth Ann Wayner


Flashback to a girl of eight riding with her family in the car.
Her eye is drawn to a billboard above Scibila’s flower/vegetable stand near the
intersection of Genesee Street and Erie Boulevard. The pointed red sword with
the twisted twin-serpent caduceus next to the words American Cancer Society had
hit a mark. Liz Wayner turned to her mother and declared that she wanted to be
doctor so she could help fight cancer.
That declaration stuck. Beside her
yearbook picture are the words…future as a doctor. Now as Dr. Elizabeth Wayner,
she is Director of Antibody Development, CD-152 at the Fred Hutchinson Cancer
Research Center at the University of Washington in Seattle.
Guided by her persistence,
determination, and intellect, her research has allowed her to participate in
the fight. In 1988 she proposed a controversial idea that could explain how
immune cells cause dangerous inflammation behind many incurable auto-immune
diseases. With further research she developed an antibody that would interfere
with the T-cell’s ability to bind to blood-vessel linings. She holds two
antibody patents. The drug, finally marketed in 2005 as Tysabri ® developed from her work and is used to prevent inflammation
associated with multiple sclerosis (MS) and helps patients with other diseases
such as lupus, Crohn’s disease, rheumatoid arthritis, and melanoma, a serious
form of skin cancer.
With that guided focus, her work
continues today in a laboratory dedicated to the development and characterization
of monoclonal antibodies. Liz enjoys research. “It is work that uses my mind
and that I find stimulating. And of course, when you can directly see the
contribution and how it helps people - that is most rewarding.”
Again, flashback to third grade at
Mott Road where her class studied Australia; “One day, I will go there,” she
said. She remembers an earth science teacher at Wellwood, a trigonometry
teacher, and Mrs. Bond the music teacher at the high school offering support
and encouragement to pursue her passions, singing and science. She sang in the
Choraliers, volunteered as a candy striper, and with a father as a Professor of
neurophysiology at Syracuse University, she had a job in the brain research
lab. Upon graduating, she attended St. Lawrence University, earning a B.S.
Magna Cum Laude with Special Honors in Biological Sciences. And then, she went to Australia. From
LaTrobe University in Melbourne she holds a Ph.D. in Behavioral Sciences.
Outside of several years spent as a
post-doctoral fellow in the UK and as an assistant professor at the University
of Minnesota, she has called Seattle home. But throughout, her focus on cell
immunology has remained. She’s been the recipient of major grants from the DOD,
National Institute of Health, American Cancer Society and the Leukemia Society
Task Force and serves as a peer reviewer for, among others, the Immunology Committee of the American Cancer
Society, and is an editorial reviewer for Cell
Adhesion and Communication; Nature; Journal of Cell Biology; Journal of
Biological Chemistry; Journal of Immunology; Journal of Clinical Investigation;
and Blood.
While Liz misses the sometimes snow in
Syracuse, she loves the Pacific Northwest and enjoys hiking, kayaking, and
wildflower photography. “I like to cook and read, and I’m a fanatic about going
to the gym,” she says of the day-to-day life she shares with her husband,
Steven Daily.
Her son is a student studying
architecture in Colorado. Her father, at 80, is still engaged in
neurophysiology in Texas, but her brother, Tim lives in Fayetteville in the
same house in which they grew up. And while the billboard near Scibila’s no
longer exists, the vision it created in the mind of an eight-year-old continues
to guide the work of a research doctor.
